Tag: NYSE:MG

  • Small Cap Most Voaltile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Zeltiq Aesthetics (NASDAQ:ZLTQ), Mistras Group (NYSE:MG), Ubic Inc (NASDAQ:UBIC)

    Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) was a big mover last session with its shares rising 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company, as the stock has lost over 22% since March 19.Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) shares after opening at $53.30 moved to $60.00 on last trade day and at the end of the day closed at $58.80.Company price to cash ratio as 27.77. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) showed a positive weekly performance of 10.88%.

    ZELTIQ Aesthetics (NASDAQ:ZLTQ) VP Carl Lamm sold 2,290 shares of ZELTIQ Aesthetics stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $19.83, for a total value of $45,410.70. Following the transaction, the vice president now directly owns 24,624 shares in the company, valued at approximately $488,294. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) shares advanced 7.07% in last trading session and ended the day on $19.23. ZLTQ return on equity ratio is recorded as -30.00% and its return on assets is -23.00%. Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) yearly performance is 457.39%.

    Mistras Group, Inc. (NYSE:MG), a leading “one source” global provider of technology-enabled asset protection solutions, reported financial results for its third quarter and first nine months of fiscal year 2014, which ended February 28, 2014.During its third quarter, the Company’s revenues increased 13.5% over prior year, reaching $151.7 million. Net income for the third quarter was $1.2 million, or $0.04 per diluted share, compared with net income of $2.8 million or $0.09 per diluted share in the prior year period. Excluding acquisition-related items, net income in the third quarter of fiscal year 2014 was $1.8 million or $0.06 per diluted share, compared with $1.9 million or $0.06 per diluted share in the prior year’s third quarter. Adjusted EBITDA was $12.5 million in the third quarter of fiscal year 2014 compared with $12.5 million in the prior year period.Mistras Group Inc (NYSE:MG) shares moved up 2.84% in last trading session and was closed at $22.81, while trading in range of $20.42-$23.38. Mistras Group Inc (NYSE:MG) year to date performance is 9.24%.

    Ubic Inc (ADR) (NASDAQ:UBIC), a leading developer of unique, behavioral informatics-based, data-analytics technology and services used in legal discovery (eDiscovery) and digital forensic investigations, announced that the company and its technology will be featured in a news report airing on CNBC (as paid programming), Wednesday, April 9 at 11:30 pm pacific time. Ubic Inc (ADR) (NASDAQ:UBIC) weekly performance is 47.29%. On last trading day company shares ended up $9.50. Ubic Inc (ADR) (NASDAQ:UBIC) distance from 50-day simple moving average is 61.09%. Analysts mean target price for the company is $7.25.